Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Clinical trials are led by early-stage investigators and/or impact health equity, veterans and pediatricsFuture funding increased to offset cuts in medical research funding CHICAGO, April 09, 2026 ...
-
Market growth is driven by rising cancer prevalence, demand for minimally invasive procedures, and advances in precision diagnostics.
-
FORT LAUDERDALE, FLORIDA, April 09, 2026 (GLOBE NEWSWIRE) -- Enabli Health, an innovative service focused on solving healthcare’s growing allied health shortages, is excited to announce its...
-
Calroy publishes new research explaining how marine-derived rhamnan sulfate may support the endothelial glycocalyx and vascular circulation.
-
Myriad will share new data at the Society of Gynecologic Oncology (SGO) Annual Meeting April 10-13, including two oral presentations and two posters.
-
WASHINGTON, April 09, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Siemens Healthineers, a leading global medical technology provider pioneering...
-
MMI (Medical Microinstruments, Inc.) today announced the commercial launch in the U.S. of its Robotic Suture.
-
Knoxville, TN, April 09, 2026 (GLOBE NEWSWIRE) -- LivTech, a leading provider of comprehensive healthcare tech solutions specifically designed for long-term post-acute care, today announced the...
-
BRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the launch of bimatoprost ophthalmic solution 0.01% (2.5 mL, 5 mL and...
-
Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and improvements in sleep-related symptoms across two Phase 2 trialsMeeting...